Skip to content
value.today

Cardiodx Inc.

Total raised
$174 M
6 rounds on record
Latest round
$18 M
Jan 2017
First round on record
May 2010
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cardiodx Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2017$18 MNo. 6$10 to $50 million

Cardiodx Inc.: Raise no. 6, Jan 2017

Investors in this round

7 investors had bought by the notice of Jan 18, 2017: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $42 M offered; $24 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Sale and issuance of (i) Series 1-A Preferred Stock, (ii) Series 1-B Preferred Stock, and (iii) Common Stock issuable upon conversion of Series 1-A Preferred Stock and Series 1-B Preferred Stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Duane G. Williams · Executive Officer
  • Jim G. Wingrove · Executive Officer
  • Khushro F. Mehta · Executive Officer, Director
  • Mark G. Monane · Executive Officer
  • Susan G. Daniels · Executive Officer
  • Tim G. Henn · Executive Officer
  • Ajit G. Singh · Director
  • David L. Levison · Director
  • Hongjie G. Hu · Director
  • Patrick G. Enright · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general corporate purposes.”

Signed by Khushro Mehta, President and CEO. Source: SEC Form D, newest notice filed Jan 18, 2017. Read the notice at the SEC.

equitySEC
Jun 2015$12 MNo. 5$10 to $50 million

Cardiodx Inc.: Raise no. 5, Jun 2015

Investors in this round

15 investors had bought by the notice of Feb 22, 2016: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $26 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Sale and issuance of Series DD-2 Preferred Stock and the underlying Common Stock issuable upon conversion thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David L. Levison · Executive Officer, Director
  • Gwen R. Carscadden · Executive Officer
  • Mark L. Monane · Executive Officer
  • Ajit G. Singh · Director
  • Andrew L. Guggenhime · Director
  • Hongjie G. Hu · Director
  • James R. Tobin · Director
  • Louis G. Lange · Director
  • Patrick G. Enright · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general corporate purposes.”

Signed by David Levison, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Feb 22, 2016. Read the notice at the SEC.

equitySEC
Jul 2014$21 MNo. 4$10 to $50 million

Cardiodx Inc.: Raise no. 4, Jul 2014

Investors in this round

14 investors had bought by the notice of Jul 24, 2014: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $25 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Sale and issuance of Series DD Preferred Stock and the underlying Common Stock issuable upon conversion thereof.
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David L. Levison · Executive Officer, Director
  • Deborah L. Kilpatrick · Executive Officer
  • Douglas T. Ross · Executive Officer
  • Gwen R. Carscadden · Executive Officer
  • Mark T. Monane · Executive Officer
  • Melinda L. Griffith · Executive Officer
  • Robert F. Werner · Executive Officer
  • Ajit G. Singh · Director
  • Andrew L. Guggenhime · Director
  • Brook H. Byers · Director
  • James R. Tobin · Director
  • Louis G. Lange · Director
  • Patrick G. Enright · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general corporate purposes.”

Signed by David Levison, President and CEO. Source: SEC Form D, newest notice filed Jul 24, 2014. Read the notice at the SEC.

equitySEC
Aug 2012$31 MNo. 3$10 to $50 million

Cardiodx Inc.: Raise no. 3, Aug 2012

Investors in this round

28 investors had bought by the notice of Aug 31, 2012: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $58 M offered; $28 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Sale and issuance of (i) Series CC-1 Preferred Stock, (ii) Series CC-2 Preferred Stock, and (iii) Common Stock issuable upon conversion of Series CC-1 Preferred Stock and Series CC-2 Preferrred Stock.
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew L. Guggenhime · Executive Officer
  • David Levison · Executive Officer, Director
  • Mark G. Weeks · Executive Officer
  • Steven G. Rosenberg · Executive Officer
  • Ajit Singh · Director
  • Arthur M. Pappas · Director
  • Brook Byers · Director
  • Fred G. Cohen · Director
  • Louis G. Lange · Director
  • Patrick Enright · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general corporate purposes including, but not limited to, executive salaries.”

Signed by David Levison, President and CEO. Source: SEC Form D, newest notice filed Aug 31, 2012. Read the notice at the SEC.

equitySEC
Feb 2011$57 MNo. 2$50 to $250 million

Cardiodx Inc.: Raise no. 2, Feb 2011

Investors in this round

17 investors had bought by the notice of Mar 2, 2011: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$57 M of $78 M offered; $21 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Sale/issuance of (i) Series AA Preferred Stock, (ii) Series BB Preferred Stock, (iii) Warrants, (iv) Series AA Preferred Stock underlying Warrants and (v) Common Stock issuable upon conversion of Seri
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$2,279,507 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Amy G. Paye · Executive Officer
  • David Levison · Executive Officer, Director
  • Mark G. Weeks · Executive Officer
  • Steven G. Rosenberg · Executive Officer
  • Arthur M. Pappas · Director
  • Brook Byers · Director
  • Fred G. Cohen · Director
  • Louis G. Lange · Director
  • Patrick Enright · Director
  • Rafael G. Torres · Director
  • William Ericson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total offering and sales amounts assume the exercise of warrants ($3,359,837.00)”
  • On the use of proceeds: “This estimate excludes amounts paid and that may be paid to the law firm which two executive officers were/are affiliated.”

Signed by David Levison, President and CEO. Source: SEC Form D, newest notice filed Mar 2, 2011. Read the notice at the SEC.

equity, optionsSEC
May 2010$35 MNo. 1$10 to $50 million

Cardiodx Inc.: Raise no. 1, May 2010

Investors in this round

16 investors had bought by the notice of May 14, 2010: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $45 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Sale and Issuance of Series D Preferred Stock and the underlying Common Stock issuable upon conversion thereof
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$723,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Amy G. Paye · Executive Officer
  • David Levison · Executive Officer, Director
  • Jeff G. Heer · Executive Officer
  • Mark G. Weeks · Executive Officer
  • Steven G. Rosenberg · Executive Officer
  • Arthur M. Pappas · Director
  • Brook Byers · Director
  • Fred G. Cohen · Director
  • Louis G. Lange · Director
  • Michael Goldberg · Director
  • Rafael G. Torres · Director
  • Risa Stack · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “This estimate excludes amounts paid and that may be paid to the law firm which two executive officers were/are affiliated and also excludes amounts previously received from the issuance of convertible promissory notes that were converted in the financing.”

Signed by David Levison, President and CEO. Source: SEC Form D, newest notice filed May 14, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cardiodx Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2017).

    SEC Form D · Jan 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2017

That is all the official record says: Cardiodx Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cardiodx Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 28 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cardiodx Inc.
NameRoleNamed in
Duane G. WilliamsExecutive officerJan 2017
Jim G. WingroveExecutive officerJan 2017
Khushro F. MehtaExecutive officerJan 2017
Mark G. MonaneExecutive officerJan 2017
Susan G. DanielsExecutive officerJan 2017
Tim G. HennExecutive officerJan 2017
David L. LevisonExecutive officerFeb 2016
Gwen R. CarscaddenExecutive officerFeb 2016
Mark L. MonaneExecutive officerFeb 2016
Mark .R. WilligExecutive officerJun 2015
Deborah L. KilpatrickExecutive officerJul 2014
Douglas T. RossExecutive officerJul 2014
Mark T. MonaneExecutive officerJul 2014
Melinda L. GriffithExecutive officerJul 2014
Robert F. WernerExecutive officerJul 2014
Andrew L. GuggenhimeExecutive officerAug 2012
David LevisonExecutive officerAug 2012
Mark G. WeeksExecutive officerAug 2012
Steven G. RosenbergExecutive officerAug 2012
Amy G. PayeExecutive officerMar 2011
Jeff G. HeerExecutive officerMay 2010
Ajit G. SinghDirectorJan 2017
David L. LevisonDirectorJan 2017
Hongjie G. HuDirectorJan 2017
Khushro F. MehtaDirectorJan 2017
Patrick G. EnrightDirectorJan 2017
Andrew L. GuggenhimeDirectorFeb 2016
James R. TobinDirectorFeb 2016
Louis G. LangeDirectorFeb 2016
Brook H. ByersDirectorJul 2014
Ajit SinghDirectorAug 2012
Arthur M. PappasDirectorAug 2012
Brook ByersDirectorAug 2012
David LevisonDirectorAug 2012
Fred G. CohenDirectorAug 2012
Patrick EnrightDirectorAug 2012
Rafael G. TorresDirectorMar 2011
William EricsonDirectorMar 2011
Michael GoldbergDirectorMay 2010
Risa StackDirectorMay 2010